CED, NCBIO, North Carolina's state-level affiliate of the national Biotechnology Industry Organization, and the North Carolina Biotechnology Center, whose mission is to provide long-term economic and societal benefits to North Carolina, have partnered to present CED's 18th annual Biotech Conference.
CED's Biotech 2009 conference unites the Southeast's life science community to celebrate one of the biotech industry's most dynamic regions. This two-day conference will focus on potential impact of the new political landscape and what biotech companies should do to prepare for the change. CED's Biotech 2009 includes world-class speakers, a variety of panels on industry topics and trends, and networking opportunities with life science leaders. The conference will be held at the new Raleigh Convention Center in Raleigh, N.C. February 16-17, 2009.
Designed for industry executives, including biotech entrepreneurs, pharmaceutical companies, research leaders, policy makers and nationally prominent investors, CED's Biotech 2009 conference will address life science and healthcare policy. Confirmed speakers for this event to date include the honorable James C. Greenwood, president and CEO of the Biotechnology Industry Organization; John J. Campbell, founder, chairman and CEO of Campbell Alliance; Dennis Gillings, chairman and CEO of Quintiles Transnational Corp.; James C. Mullen, president and CEO of Biogen; Colin Goodard, CEO of OSI Pharmaceuticals, Inc.; and H. Stewart Parker, president and CEO of Targeted Genetics Corporation.
To learn more about CED's Biotech conference, visit www.cednc.org/biotech or call 919.549.7500.